Straumann Holding AG (SAUHY)
12.85
-0.08
(-0.62%)
USD |
OTCM |
May 03, 16:00
Straumann Debt to Equity Ratio: 0.1089 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1089 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.2592 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.3209 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.3983 |
| June 30, 2020 | 0.6724 |
| December 31, 2019 | 0.1467 |
| June 30, 2019 | 0.4154 |
| December 31, 2018 | 0.1664 |
| June 30, 2018 | 0.2521 |
| December 31, 2017 | 0.1854 |
| June 30, 2017 | 0.3871 |
| December 31, 2016 | 0.315 |
| Date | Value |
|---|---|
| June 30, 2016 | 0.2809 |
| December 31, 2015 | 0.3298 |
| June 30, 2015 | 0.3654 |
| December 31, 2014 | 0.2706 |
| June 30, 2014 | 0.3025 |
| December 31, 2013 | 0.3157 |
| June 30, 2013 | 0.3326 |
| December 31, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.0028 |
| June 30, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
0.6724
Maximum
Jun 2020
0.2322
Average
0.2029
Median
Debt to Equity Ratio Benchmarks
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | 0.00 |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.955B |
| Total Liabilities (Quarterly) | 1.766B |
| Shareholders Equity (Quarterly) | 2.186B |
| Current Ratio | 1.947 |
| Net Debt Paydown Yield | -0.31% |